A RC198 Study in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors

Clinical trial NCT05867303 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05867303
Sponsor: RemeGen Co., Ltd.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Melanoma Urothelial Carcinoma Renal Cell Carcinoma Non-small Cell Lung Cancer Head and Neck Squamous Cell Carcinoma Colorectal Carcinoma

Start date: 2023-06-05
Primary completion: 2024-09-30
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.